Maine’s Medical Cannabis Program Faces Uncertainty Over Testing Requirements
The Maine Legislature is currently debating new testing requirements for medical cannabis, but there is a fundamental disagreement over what is already allowed and mandated. Unlike the recreational market, which requires contaminant and potency testing for all products, Maine’s medical cannabis program does not have such requirements.
Representative Marc Malon (D-Biddeford) has proposed a plan that aligns with Governor Janet Mills’ administration, which aims to establish testing protocols for medical cannabis. However, some lawmakers and cannabis businesses argue that the state is not using its existing testing authority.
The Office of Cannabis Policy (OCP) has the authority to inspect and test products from dispensaries and caregivers, but it is not doing so annually. The OCP claims it lacks the necessary staff and resources to conduct such testing. Critics argue that this is a lack of enforcement, rather than a lack of authority.
The OCP has conducted testing on samples from caregivers in the past, but critics argue that this testing is only being done because the office is using its authority to collect and test samples for a study. The study found that 42% of the samples contained at least one material banned in the recreational program.
The disagreement over testing requirements is not just about what is required, but also about what constitutes a failed test. The recreational program has a clear framework for failed tests, but the medical program does not. This lack of clarity is causing uncertainty for both lawmakers and cannabis businesses.
Some lawmakers, such as Senator Craig Hickman (D-Kennebec), disagree with the OCP’s claim that it does not have the authority to enforce testing requirements. They argue that the rules are still in place and that the office is simply not enforcing them.
The debate over testing requirements is part of a larger discussion about the regulation of Maine’s medical cannabis program. Some argue that the program needs more oversight, while others argue that the current regulations are too burdensome and could drive small businesses out of the market.
Ultimately, the outcome of the debate will depend on the Legislature’s ability to find a compromise that balances the need for testing with the need for businesses to operate.
